---
schema_version: "secwatch.filing_event.v1"
accession: "0001528287-25-000012"
form_type: "8-K"
ticker: "NPCE"
cik: "0001528287"
company_name: "NeuroPace Inc"
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T15:34:57.536188+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# NeuroPace reports record Q1 revenue $22.5M (+24% YoY), raises FY2025 guidance to $93-97M

## Summary
- Record quarterly revenue $22.5M, up 24% YoY; RNS System revenue up 29% excluding NAUTILUS study implants.
- Gross margin 77.0% exceeded full-year guidance of 73-75%; operating loss narrowed to $5.1M from $7.5M.
- Full-year 2025 revenue guidance raised to $93-97M (16-21% growth); expects NAUTILUS topline data in H2 2025.
- Strategic refocus on core RNS System; terminating SEEG distribution relationship starting Q4 2025 through Q1 2026.
- Cash and investments $66.3M; long-term debt $59.8M as of March 31, 2025.

## SEC filing metadata
- accession: 0001528287-25-000012
- form_type: 8-K
- ticker: NPCE
- cik: 0001528287
- company_name: NeuroPace Inc
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1528287/000152828725000012/0001528287-25-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1528287/000152828725000012/npce-20250513.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001528287-25-000012
- JSON: https://secwatch.observer/filing/0001528287-25-000012.json
- Plain text: https://secwatch.observer/filing/0001528287-25-000012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.